Credit Suisse Healthcare Conference. November 11, Dan Brennan, EVP & CFO
|
|
- Polly Lillian Casey
- 5 years ago
- Views:
Transcription
1 Credit Suisse Healthcare Conference November 11, 2014 Dan Brennan, EVP & CFO 1
2 Safe harbor for forward-looking statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of Forward-looking statements may be identified by words like anticipate, expect, project, believe, plan, estimate, intend and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could differ materially from the expectations and projections expressed or implied by our forward-looking statements. Factors that may cause such differences can be found in our most recent Form 10-K and Forms 10-Q filed or to be filed with the Securities and Exchange Commission under the headings Risk Factors and Safe Harbor for Forward-Looking Statements. Accordingly, you are cautioned not to place undue reliance on any of our forward-looking statements. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which they may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. 2 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
3 Disclaimers This presentation includes products that have not been approved or cleared by the U.S. Food and Drug Administration and are not available for sale in the U.S. All future product approval and launch dates are based on estimates of completion of regulatory submissions, review and approval or clearance, as well as other business considerations. For reconciliations of non-gaap financial measures used in these presentations to the most directly comparable GAAP figures, please refer to the Investor Relations section of our website at 3 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
4 An industry leader in large markets Rhythm Management $2.0B Cardiac Rhythm Management $1.9B MedSurg $2.2B Neuromodulation $454M Electrophysiology $155M Endoscopy $1.3B Cardiovascular $2.8B Interventional Cardiology $2.0B Urology & Women s Health $505M Peripheral Interventions $805M 2013 Revenue = $7.143B as reported 4 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
5 Building a winning foundation Building momentum: exceeding plans and expectations Competing in large global markets: challenging but opportunities exist Executing our strategic plan: accelerating sales and adjusted EPS growth Delivering meaningful innovation: developing a differentiated pipeline Leading globally: fostering a winning spirit 5 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
6 Financial goals: Consistent revenue & EPS growth BSC Financial Goals Above-market revenue growth Expanding operating margins Leveraged earnings growth Operational Revenue Growth* Adjusted Op. Margin* Investor Day Guidance Actual YTD Q3:2014 (2%) to 2% +2% +5% 18% to 19% 19% 20.1% +104bps Y/Y Strong cash flow Adjusted EPS* $0.64 to $0.70 $0.73 $ % Y/Y Consistency of results Adjusted FCF* Strong cash flow Strong cash flow $760M Source: BSC estimates. All numbers are Non-GAAP and exclude goodwill and other intangible asset impairment charges, acquisition and divestiture-related net credits, litigation, and restructuring-related charges, discrete tax items and amortization expense. For reconciliations of non-gaap financial measures to the most directly comparable GAAP figures, please refer to the Investor Relations section of our website at 6 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
7 Differentiated margin expansion opportunity Operating Margin* Expansion 30% 25% 20% 15% Grow revenue faster than market rates Launch new products with accretive margins Lean business initiatives and restructuring 10% Drive SG&A efficiencies 5% Reduce corporate infrastructure 0% 2013A 2017E Leveraged sales growth Goal of double digit EPS growth *Adjusted Operating Margin is non-gaap and excludes goodwill and other intangible asset impairment charges, acquisition and divestiture-related net credits, litigation, and restructuring-related charges, discrete tax items and amortization expense. For reconciliations of non-gaap financial measures to the most directly comparable GAAP figures, please refer to the Investor Relations section of our website at 7 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
8 Q3:14 results reflect progress Balanced revenue growth Cardiovascular +8%, Rhythm Management +7%, MedSurg +5% Y/Y* Interventional Cardiology +8%, CRM +4% Y/Y* Continued margin expansion Rhythm Management (CRM + EP) Adj. Op. Margin 14.1%, +160bps Y/Y BSX Adj. Op. Margin 20.5%, +120bps Y/Y Double digit adjusted EPS growth Adjusted EPS $0.20, +20% Y/Y *Growth rates are on a constant currency basis. Constant currency growth rates, adjusted operating margin, and adjusted EPS are non-gaap financial measures; for reconciliations of non-gaap financial measures to the most directly comparable GAAP figures, please refer to the Investor Relations section of our website at 8 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
9 Strategic imperatives align execution STRENGTHEN Execution to Grow Share EXPAND Into High Growth Adjacencies DRIVE Global Expansion FUND The Journey to Fuel Growth DEVELOP Key Capabilities Improved core growth Adjacencies to contribute meaningfully to growth Emerging markets to grow to 15% of revenue by 2017* Operating margin** projected to improve to 25% by 2017 New commercial capabilities to help teams deliver plan *Growth rates are on a constant currency basis. **Adjusted operating margin. Constant currency growth rates and adjusted operating margin are both non-gaap financial measures; for reconciliations of non-gaap financial measures to the most directly comparable GAAP figures, please refer to the Investor Relations section of our website at Source: BSC estimates 9 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
10 Innovating to drive share gains in core markets AUTOGEN X4 ACUITY X4 S-ICD World s smallest & thinnest devices Longevity advantage Promus PREMIER Next gen quad lead CE Mark US IDE trial enrolling Synergy Protection without touching the heart $100M revenue 2014E PRECISION SPECTRA Launched WW Enhanced delivery Premier outcomes Targeted 90-day drug & polymer absorption First 32-contact & multiple lead spinal cord stim. platform Caution: In the U.S., ACUITY X4 quadripolar LV leads, ACUITY PRO lead delivery system, and Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System are investigational devices and not available for sale. 10 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
11 Market expansion with differentiated portfolio Watchman Lotus Deep Brain Stim Left Atrial Appendage Closure; CE Mark Goal H1:15 US Aortic valve repair Expanding in EU U.S. IDE trial enrolling 1M Americans with Parkinson s disease US IDE trial enrolling Rhythmia Alair Next gen mapping & navigation system Initial installs Q3:14 Treatment for severe asthma patients 420 sites WW Caution: In the U.S., the Watchman LAA closure device, the Lotus percutaneous valve and Vercise DBS system are investigational devices and not available for sale. 11 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
12 Driving global expansion BSC Revenue 2013 BSC Revenue 2017E U.S. 52% International ** 40% Emerging Markets 8% U.S. 46% International ** 39% Emerging Markets 15% Global operating units U.S. Local leadership 47% Focus on physician training Expanded product registrations 2013 EM revenue +20%* 2013 BRIC revenue +27% Y/Y* *Growth rates are on a constant currency basis. Constant currency growth rates are non-gaap financial measures; for reconciliations of non-gaap financial measures to the most directly comparable GAAP figures, please refer to the Investor Relations section of our website at **Excluding Emerging Markets. 12 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
13 Advancing science for life Mission: We are dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Values: Caring Meaningful Innovation High Performance Global Collaboration Diversity Winning Spirit 13 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
14 Building a winning foundation Building momentum: exceeding plans and expectations Competing in large global markets: challenging but opportunities exist Executing our strategic plan: accelerating sales and adjusted EPS growth Delivering meaningful innovation: developing a differentiated pipeline Leading globally: fostering a winning spirit 14 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
15 Advancing science for life Changing Lives Through Meaningful Innovation 15 Boston Scientific Credit Suisse Healthcare Conference November 11, 2014
22 nd Annual Credit Suisse Healthcare Conference. November 12, nd Annual Credit Suisse Healthcare Conference November 12, 2013.
22 nd Annual Credit Suisse Healthcare Conference November 12, 2013 1 Safe Harbor For Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of
More informationinvestmnt Conference August 5, 2015 Susie Lisa, CFA Vice President, Investor Relations
investmnt Conference August 5, 2015 Susie Lisa, CFA Vice President, Investor Relations 1 Safe harbor for forward-looking statements and Disclaimers This presentation contains forward-looking statements
More informationCiti's Global Health Care Conference. February 25, 2013
Citi's Global Health Care Conference February 25, 2013 1 Boston Scientific Citi Global Healthcare Conference, Feb 25, 2013. Refer to appendix to this presentation for certain regulatory and financial disclosures.
More informationBOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2013
FOR IMMEDIATE RELEASE BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2013 Fourth Quarter Marks Third Consecutive Quarter of Improved Performance Natick, Mass. (February
More informationBOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER ENDED SEPTEMBER 30, 2014
FOR IMMEDIATE RELEASE BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER ENDED SEPTEMBER 30, 2014 Marlborough, Mass. (October 22, 2014) -- Boston Scientific Corporation (NYSE: BSX) generated sales of
More informationJ.P. Morgan 34 th Annual Healthcare Conference January 12, 2016
J.P. Morgan 34 th Annual Healthcare Conference January 12, 2016 Mike Mahoney President and Chief Executive Officer Safe harbor for forward-looking statements This presentation contains forward-looking
More informationBOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2016
FOR IMMEDIATE RELEASE BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2016 Marlborough, Mass. (February 2, 2017) -- Boston Scientific Corporation (NYSE: BSX) generated
More informationQ Highlights. October 26, 2017
Q3 2017 Highlights October 26, 2017 Safe Harbor for forward-looking statements and Use of Document: Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within
More informationBernstein s 34 th Annual Strategic Decisions Conference
Bernstein s 34 th Annual Strategic Decisions Conference Mike Mahoney Chairman and Chief Executive Officer Safe Harbor for Forward-Looking Statements This presentation contains forward-looking statements
More information35 th Annual JP Morgan Healthcare Conference
35 th Annual JP Morgan Healthcare Conference Mike Mahoney Chairman & CEO J A N U A R Y 10, 2 0 1 7 1 Safe Harbor for Forward-Looking Statements This presentation contains forward-looking statements within
More informationBOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017
FOR IMMEDIATE RELEASE BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017 Marlborough, Mass. (February 1, 2018) -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.408
More informationBOSTON SCIENTIFIC ANNOUNCES PRELIMINARY UNAUDITED SALES FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017
FOR IMMEDIATE RELEASE BOSTON SCIENTIFIC ANNOUNCES PRELIMINARY UNAUDITED SALES FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017 Marlborough, Mass. (January 9, 2018) -- Boston Scientific Corporation
More informationQ Highlights. April 25, 2018
2018 Highlights April 25, 2018 Safe Harbor for Forward-Looking Statements and Use of Document: Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within the
More informationJP Morgan Conference. Jim Tobin Chief Executive Officer January 14, 2009
JP Morgan Conference Jim Tobin Chief Executive Officer January 14, 2009 Cautionary Statement for Purposes of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995 This presentation
More informationQ Highlights. July 25, 2018
Q2 2018 Highlights July 25, 2018 Safe Harbor for Forward-Looking Statements and Use of Document: Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within
More informationQ Highlights. February 1, 2018
Q4 2017 Highlights February 1, 2018 Safe Harbor for Forward-Looking Statements and Use of Document: Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within
More informationBOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2007
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2007 Natick, MA (April 23, 2007) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter
More informationTranscatheter Cardiovascular Therapeutics Investor Update October 30, 2017
Transcatheter Cardiovascular Therapeutics Investor Update October 30, 2017 Kevin Ballinger Executive Vice President and President, Interventional Cardiology Professor Ian Meredith, A.M. Executive Vice
More informationTranscatheter Cardiovascular Therapeutics 2018
Transcatheter Cardiovascular Therapeutics 2018 Jeff Mirviss, SVP & President, Peripheral Interventions Kevin Ballinger, EVP & President, Interventional Cardiology Dr. Ian Meredith, EVP & Global Chief Medical
More informationQ Highlights. October 24, 2018
Q3 Highlights October 24, Safe Harbor for Forward-Looking Statements and Use of Document: Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within the meaning
More informationCredit Suisse 26 th Annual Healthcare Conference. Joe Fitzgerald, EVP and President, Rhythm Management
Credit Suisse 26 th Annual Healthcare Conference Joe Fitzgerald, EVP and President, Rhythm Management 1 Safe Harbor for Forward-Looking Statements and Regulatory Disclaimers This presentation contains
More informationBoston Scientific Corporation
March 06, 2015 Boston Scientific Corporation Current Recommendation Prior Recommendation Outperform Date of Last Change 10/16/2011 Current Price (03/05/15) $16.97 Target Price $18.00 NEUTRAL SUMMARY (BSX-NYSE)
More informationAbbott Reports First-Quarter 2019 Results
News Release Abbott Reports First-Quarter 2019 Results Sales and EPS growth exceed guidance; projects strong full-year outlook Long-term growth drivers including FreeStyle Libre, MitraClip and Alinity
More informationQ Highlights. February 6, 2019
Q4 2018 Highlights February 6, 2019 Safe Harbor for Forward-Looking Statements and Use of Document: Safe Harbor for forward-looking statements: This presentation contains forward-looking statements within
More informationAbbott Reports Second-Quarter 2018 Results
News Release Abbott Reports Second-Quarter 2018 Results Second-quarter reported sales growth of 17.0 percent; GAAP EPS from continuing operations of $0.40 Second-quarter organic sales growth of 8.0 percent
More informationAbbott Reports Fourth-Quarter 2017 Results
News Release Abbott Reports Fourth-Quarter 2017 Results Fourth-quarter reported sales growth of 42.3 percent; comparable operational sales growth of 7.7 percent Numerous new product approvals and launches
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Healthcare Conference, September 2017 NASDAQ: NOVT 1 Safe Harbor Statement The statements in this presentation
More information4Q18 Earnings Conference Call
4Q18 Earnings Conference Call February 21, 2019 ITGR: 4Q18 Earnings Conference Call / February 21, 2019 / Page 1 Presentation of Financial Information & Forward-Looking Statements Historical financial
More information2Q18 Earnings Conference Call. August 2, 2018
2Q18 Earnings Conference Call August 2, 2018 Presentation of Financial Information & Forward-Looking Statements Historical financial and operating data in this presentation reflect the consolidated results
More informationUBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017
UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers February 2018 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement The statements in this
More informationSymetis Transaction Strategic and Financial Highlights. March 30, 2017
Symetis Transaction Strategic and Financial Highlights March 30, 2017 1 Safe Harbor for Forward-Looking Statements This material contains forward-looking statements within the meaning of federal securities
More informationEndo International plc
Endo International plc Q2 2015 Earnings Report August 10, 2015 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private
More informationOur Transformation Continues Sidoti NDR May 29-30, 2018
Our Transformation Continues Sidoti NDR May 29-30, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation,
More informationShareholders. To Our. Delivering on an Innovation- Based Growth Strategy
To Our Shareholders Daniel J. Starks Chairman, President and Chief Executive Officer Our vision is to transform the treatment of expensive epidemic diseases. We do this by creating cost-effective medical
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationOur Transformation Continues. March 21, 2018
Our Transformation Continues March 21, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation, we make
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO
J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations
More informationFebruary 21, Conduent Q4 & FY 2017 Earnings Results
February 21, 2018 Conduent Q4 & FY 2017 Earnings Results Cautionary Statements Forward-Looking Statements This report contains forward-looking statements that involve risks and uncertainties. These statements
More informationPress Information. June 28, 2017
Press Information June 28, 2017 Philips to acquire The Spectranetics Corporation to accelerate expansion in imageguided therapy devices to treat cardiac and peripheral vascular disease Highly complementary
More informationMYERS INDUSTRIES, INC. Third Quarter 2018 Earnings Presentation
MYERS INDUSTRIES, INC. Third Quarter 2018 Earnings Presentation SAFE HARBOR STATEMENT & NON-GAAP MEASURES Statements in this presentation include forward-looking statements within the meaning of the Private
More informationINVESTOR PRESENTATION FEBRUARY 2019
INVESTOR PRESENTATION FEBRUARY 2019 SAFE HARBOR AND NON-GAAP Safe Harbor Statement This presentation contains certain comments that are forwardlooking statements, including sales, GAAP diluted EPS, and
More informationFourth Quarter Fiscal Year 2017
Fourth Quarter Fiscal Year 2017 October 25, 2017 J. Michael Bruff Vice President Investor Relations Mike.Bruff@Varian.com This presentation is intended exclusively for investors. It is not intended for
More informationINVESTOR PRESENTATION DECEMBER 2018
INVESTOR PRESENTATION DECEMBER 2018 SAFE HARBOR AND NON-GAAP Safe Harbor Statement This presentation contains certain comments that are forwardlooking statements, including sales, GAAP diluted EPS, and
More informationAbbott Reports Third-Quarter 2018 Results
News Release Abbott Reports Third-Quarter 2018 Results Third-quarter reported sales growth of 12.1 percent; organic sales growth of 7.8 percent Third-quarter GAAP EPS from continuing operations of $0.31;
More information2017 Second Quarter August 3, 2017
2017 Second Quarter August 3, 2017 Safe Harbor Disclaimer Cautionary Statement Regarding Forward-Looking Statements We have made statements in this document that are forward-looking statements within the
More informationCONSOLIDATED FINANCIAL STATEMENTS
FINANCIAL TABLE OF CONTENTS 2 Management s discussion and analysis of financial condition and results of operations 23 Consolidated statements of operations 2003 CONSOLIDATED FINANCIAL STATEMENTS 24 Consolidated
More informationFOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationMEDTRONIC, INC. REVENUE BY OPERATING SEGMENT - WORLD WIDE (Unaudited)
REVENUE BY OPERATING SEGMENT - WORLD WIDE ($ millions) 1 2 3 4 1 2 3 4 FY09 FY09 FY09 FY09 FY09 FY10 FY10 FY10 FY10 FY10 QTR 1 QTR 2 QTR 3 QTR 4 Total QTR 1 QTR 2 QTR 3 QTR 4 Total REPORTED REVENUE : CARDIAC
More informationFourth Quarter and Full Year 2017 Results Conference Call. March 9, 2018
Fourth Quarter and Full Year 2017 Results Conference Call March 9, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking
More informationMEDTRONIC, INC. REVENUE BY OPERATING SEGMENT - WORLD WIDE (Unaudited)
REVENUE BY OPERATING SEGMENT - WORLD WIDE ($ millions) 1 2 3 4 1 2 3 4 FY09 FY09 FY09 FY09 FY09 FY10 FY10 FY10 FY10 FY10 QTR 1 QTR 2 QTR 3 QTR 4 Total QTR 1 QTR 2 QTR 3 QTR 4 Total REPORTED REVENUE : CARDIAC
More informationThird Quarter 2018 Teleconference Supplemental Data
Third Quarter 2018 Teleconference Supplemental Data Cautionary Statement Forward-Looking Information This communication contains forward looking statements as that term is defined in the Private Securities
More informationSecond Quarter 2018 Earnings Results
Second Quarter 2018 Earnings Results August 1, 2018 Finn, VNS Therapy Patient Safe Harbor Certain statements in this presentation, other than purely historical information, are forward-looking statements
More information2018 SECOND QUARTER FINANCIAL RESULTS
2018 SECOND QUARTER FINANCIAL RESULTS July 30, 2018 0 SAFE HARBOR STATEMENT The 2018 second quarter news release, conference call webcast, and the following slides contain forward-looking statements. The
More informationBOSTON SCIENTIFIC CORPORATION
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Í ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or For the fiscal year ended December
More informationThird Quarter 2018 Results Conference Call. November 7, 2018
Third Quarter 2018 Results Conference Call November 7, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationAcquisition of Dealer Inspire and Launch Digital Marketing
Acquisition of Dealer Inspire and Launch Digital Marketing Investor Presentation February 14, 2018 Forward Looking Statements This presentation contains forward looking statements within the meaning of
More informationMYERS INDUSTRIES, INC. Second Quarter 2018 Earnings Presentation
MYERS INDUSTRIES, INC. Second Quarter 2018 Earnings Presentation SAFE HARBOR STATEMENT & NON-GAAP MEASURES Statements in this presentation concerning the Company s goals, strategies and expectations for
More information2018 FOURTH QUARTER EARNINGS CALL
NORTH AMERICA S LEADING BUILDING MATERIALS DISTRIBUTOR RESIDENTIAL COMMERCIAL INTERIOR SOLAR 2018 FOURTH QUARTER EARNINGS CALL Forward Looking Statements / Non-GAAP Measures This presentation contains
More informationConduent Reports Third Quarter 2017 Results; Operating Income and Adjusted EBITDA Rise; Strong Cash Flow and Adjusted EPS; Healthy Renewal Rate
News from Conduent Conduent Incorporated 100 Campus Drive, Suite 200 Florham Park, NJ 07932 www.conduent.com Conduent Reports Third Quarter 2017 Results; Operating Income and Adjusted EBITDA Rise; Strong
More informationPolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014
PolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014 PolyOne Corporation Page 1 Forward-Looking Statements In this presentation, statements that
More informationJune Investor Presentation
June 2014 Investor Presentation Safe Harbor Certain statements included herein, including guidance and those that express management's objectives and the strategies to achieve those objectives, as well
More informationMYERS INDUSTRIES, INC. MARCH 9, 2017 FOURTH QUARTER & FULL YEAR EARNINGS PRESENTATION
MYERS INDUSTRIES, INC. MARCH 9, 2017 FOURTH QUARTER & FULL YEAR EARNINGS PRESENTATION SAFE HARBOR STATEMENT Statements in this presentation concerning the Company s goals, strategies, and expectations
More informationJuly 24, Q Supplemental Information
July 24, 2018 Q2 2018 Supplemental Information Non-GAAP Disclaimer The financial results disclosed in this presentation include certain measures calculated and presented in accordance with GAAP. In addition
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Joe Woody Chief Executive Officer
J.P. MORGAN HEALTHCARE CONFERENCE Joe Woody Chief Executive Officer 0 OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and webcast, including our outlook, expectations and planning
More informationMSCI. J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO. February 28, 2017
MSCI J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO February 28, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document.
More informationAvnet Fiscal First Quarter 2019 Financial Results. Bill Amelio Chief Executive Officer
Avnet Fiscal First Quarter 2019 Financial Results Bill Amelio Chief Executive Officer Safe harbor statement This document contains certain forward-looking statements within the meaning of Section 27A of
More informationLazard Capital Markets 9 th Annual Healthcare Conference
Lazard Capital Markets 9 th Annual Healthcare Conference November 14, 2012 Glenn P. Muir Executive VP and CFO 1 Forward-Looking Statements This presentation contains forward-looking information that involves
More informationMSCI THIRD QUARTER 2016
MSCI THIRD QUARTER 2016 Earnings Presentation October 27, 2016 2016 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. FORWARD-LOOKING STATEMENTS Forward-Looking
More informationAbbott Reports First-Quarter 2018 Results
News Release Abbott Reports First-Quarter 2018 Results First-quarter reported sales growth of 16.7 percent; GAAP EPS from continuing operations of $0.23 First-quarter organic sales growth of 6.9 percent
More informationJ.P. MORGAN HEALTHCARE CONFERENCE January 10, 2017
J.P. MORGAN HEALTHCARE CONFERENCE January 10, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments
More informationSafe Harbor and Non-GAAP Measures
Safe Harbor and Non-GAAP Measures Forward-Looking Statements This presentation contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements
More informationZimmer Biomet Reports Second Quarter 2016 Financial Results
July 28, 2016 Zimmer Biomet Reports Second Quarter 2016 Financial Results -- Net Sales of $1.934 billion represent an increase of 65.6% over the prior year period, and an increase of 4.5% on an adjusted
More informationGardner Denver Q Earnings Presentation. April 27, 2018
Gardner Denver Q1 2018 Earnings Presentation April 27, 2018 Replay Information Dial toll-free: +1.877.344.7529 International: +1.412.317.0088 Conference ID: #10119481 Log on to: http://investors.gardnerdenver.com
More informationLivaNova Update. December, 2015
LivaNova Update December, 2015 Forward-looking statements This presentation contains forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended,
More informationQ EARNINGS Presentation
Q1 2018 EARNINGS Presentation Disclosures This presentation contains non-gaap financial measures relating to our performance. You can find the reconciliation of these measures to the most directly comparable
More informationA leading provider of post acute services
A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More informationAvnet Investor Presentation. Sale of Technology Solutions to Tech Data Corp.
Avnet Investor Presentation Sale of Technology Solutions to Tech Data Corp. September 19, 2016 1 Safe Harbor Statement This presentation contains certain forward-looking statements within the meaning of
More informationDANAHER CORPORATION Tom Joyce, President & CEO J.P. MORGAN HEALTHCARE CONFERENCE JANUARY 8, 2019
DANAHER CORPORATION Tom Joyce, President & CEO J.P. MORGAN HEALTHCARE CONFERENCE JANUARY 8, 2019 Forward Looking Statements Statements in this presentation that are not strictly historical, including any
More informationSafe Harbor and Non-GAAP Measures
Safe Harbor and Non-GAAP Measures Forward-Looking Statements This presentation contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements
More informationPlease note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the
Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation January 13, 2015 and should not be considered
More information2017 First Quarter May 3, 2017
2017 First Quarter May 3, 2017 Safe Harbor Disclaimer Cautionary Statement Regarding Forward-Looking Statements We have made statements in this document that are forward-looking statements within the meaning
More informationMYERS INDUSTRIES, INC. First Quarter 2018 Earnings Presentation
MYERS INDUSTRIES, INC. First Quarter 2018 Earnings Presentation SAFE HARBOR STATEMENT & NON-GAAP MEASURES Statements in this presentation concerning the Company s goals, strategies and expectations for
More informationBlack Box Corporation Investor Presentation
Black Box Corporation Investor Presentation Black Box Corporation Forward-Looking Statements - Any forward-looking statements contained in this presentation are made pursuant to the safe harbor provisions
More informationWest Pharmaceutical Services, Inc. Third-Quarter 2018 Analyst Conference Call 9 a.m. Eastern Time, October 25, 2018
West Pharmaceutical Services, Inc. Third-Quarter 2018 Analyst Conference Call 9 a.m. Eastern Time, October 25, 2018 Speakers: Eric M. Green President and Chief Executive Officer Bernard J. Birkett Senior
More informationCantel Medical Reports Financial Results for its First Quarter Fiscal Year 2019
Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2019 November 29, 2018 Medical segment leads with strong double-digit growth - Net sales of $225.6M, up 6.0%, with organic sales
More informationHelping Clients Win with Digital
First Quarter 2018 Earnings Supplement Helping Clients Win with Digital May 7, 2018 2017 Cognizant Forward Looking Statements and Non-GAAP Financial Measures This earnings supplement includes statements
More informationJuly 26, Second Quarter 2018 Earnings Presentation
July 26, 2018 Second Quarter 2018 Earnings Presentation Disclaimer Statement Regarding Safe Harbor For Forward-Looking Statements This presentation contains forward-looking statements, that is, information
More informationECOLAB THIRD QUARTER 2018
3Q 2018 Overview Sales: ECOLAB THIRD QUARTER 2018 Reported sales +5%; fixed currency sales were +6%, with acquisition adjusted fixed currency sales +7%. New business growth, share gains, pricing and new
More informationRaymond James Tech Conference. December 5, 2017
Raymond James Tech Conference December 5, 2017 Forward-looking statements The following information contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationAccelerating the Shift to Digital
Fourth Quarter 2017 Earnings Supplement Accelerating the Shift to Digital February 7, 2018 2017 Cognizant Forward Looking Statements and Non-GAAP Financial Measures This earnings supplement includes statements
More informationINVESTOR BRIEFING. Our vision:
INVESTOR BRIEFING August 2016 NYSE: BMS Our vision: A passionate commitment to the growth and success of our customers will make Bemis the clear choice for inspired packaging solutions SAFE HARBOR STATEMENT
More information2016 Fourth Quarter February 22, 2017
2016 Fourth Quarter February 22, 2017 Safe Harbor Disclaimer Cautionary Statement Regarding Forward-Looking Statements We have made statements in this document that are forward-looking statements within
More informationEndo International plc
Endo International plc UBS Global Healthcare Conference May 21, 2014 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of
More informationInnovation. It s at the core of everything we do ANNUAL REPORT
Innovation. It s at the core of everything we do. 2011 ANNUAL REPORT 2 Letter to Our Employees and Stockholders Improving Lives 6 Jenny is running today, but not to the emergency room, thanks to a groundbreaking
More informationINVESTOR BRIEFING. Our vision:
INVESTOR BRIEFING February 2017 NYSE: BMS Our vision: A passionate commitment to the growth and success of our customers will make Bemis the clear choice for inspired packaging solutions SAFE HARBOR STATEMENT
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationSECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017
SECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017 SECOND QUARTER EARNINGS CALL AGENDA CEO Transition Robert Abernathy Chairman Strategic Vision Joe Woody Chief Executive Officer Second Quarter Results and
More information2015 Fourth Quarter February 25, 2016
2015 Fourth Quarter February 25, 2016 Safe Harbor Disclaimer Forward-Looking Statements We have made statements in this document that are forward-looking statements within the meaning of the federal securities
More information